BOXED WARNING Contraindicated in patients <6 yr (fatal dehydration in juvenile mice); avoid in patients 6 to <18 yr
FDA dosing
Population
Start
Target
Max
Chronic idiopathic constipation (CIC)
Adults
3 mg QD
3 mg QD
3 mg QD
Irritable bowel syndrome with constipation (IBS-C)
Adults
3 mg QD
3 mg QD
3 mg QD
Renal Undefined
Hepatic Undefined
Instructions
Take with or without food; swallow tablet whole
For swallowing difficulty or NG/G-tube: may crush and mix with applesauce or water
Available strengths
tab 3 mg
Contraindications
Patients <6 years of age (risk of serious dehydration)
Known or suspected mechanical GI obstruction
Cautions
Diarrhea, may be severe — suspend dosing and rehydrate
Risk of serious dehydration in pediatric patients
Adverse reactions
Diarrhea
Pregnancy Negligibly absorbed; fetal exposure not expected; data insufficient
Lactation Not measurable in breast milk; clinically relevant infant exposure not expected
Cost
Plecanatide (TRULANCE)
Strength
#/mo
generic $/mo
CostPlus
3 mg
tab
30 qd
not offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Plecanatide is dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.